EdgarLookup

Lineage Cell Therapeutics, Inc.

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Lineage Cell Therapeutics, Inc.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

IMDX
Company Title Type Shares Price Value Date
IMDX Sale 2,383,090 $2.16 $5,147,474 Jan 2, 2020
IMDX Sale 4,000,000 $1.66 $6,640,000 Sep 11, 2019